Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article. “
“Streptococcus pyogenes causes a broad spectrum of acute infections and is the bacterium most frequently GDC-0199 in vitro isolated from patients with pharyngitis. A number of antibiotics including penicillin have been shown to be effective, although antibiotic treatment
failure in cases of streptococcal pharyngitis have been reported. Herein, we aimed to elucidate the features of recurrent strains using clinical isolates. Ninety-three S. pyogenes organisms were obtained from Japanese patients with recurrent pharyngitis. Following genetic characterization, M-type isolates from patients with recurrent pharyngitis differed from those obtained at initial onset in 11 of 49 episodes, and pulsed field gel electrophoresis analysis showed different patterns in those cases. Additionally, spe genotyping revealed click here that the Spe type of the strains obtained at secondary onset corresponded with those from the initial onset in 22 cases. Furthermore, antibiotic
susceptibility testing revealed that more than half of the strains were resistant to macrolides and lincosamides, which was a much greater ratio as compared with the strains obtained from initial onsets in previous studies. Our results suggest that recurrence and reinfection are often confused during the diagnosis of repetitive and persistent streptococcal pharyngitis. Moreover, the present S. pyogenes
organisms were less susceptible to antibiotics, which raises caution about their appropriate use in clinical practice. Streptococcus pyogenes, also known as Group A Streptococcus, is a common human pathogen that causes a broad spectrum of acute infectious diseases ranging from noninvasive diseases, such as Tacrolimus (FK506) pharyngitis, skin infections, and acute rheumatic fever, to more life-threatening invasive infections, including myositis, necrotizing fasciitis, sepsis, and streptococcal toxic shock syndrome (Cunningham, 2000). Streptococcal pharyngitis is frequently observed in infants and adolescents, and most bacterial pharyngitis cases are caused by S. pyogenes. A variety of antibiotics have been suggested to be effective for treating streptococcal pharyngitis, including penicillins, cephalosporins, macrolides, and lincosamides. Currently, penicillin remains the treatment of choice, because of its proven efficacy and safety, narrow spectrum, and low cost (Dajani et al., 1995; Bisno et al., 2002). However, antibiotic treatment failure has been reported in clinical cases of streptococcal pharyngitis (Macris et al., 1998; Kuhn et al., 2001). Several theories have been proposed to account for this phenomenon, including the coexistence of β-lactamase-producing bacteria (Brook, 1994) and internalization of S.